Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 6,659
Sponsored by: The Breast Cancer Site

Today, the vast majority of medical research is done on men, with women compromising only one-third of test subjects.

The cause and rationale behind this is a long and complex one. In 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. Women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

But for those women who are willing to participate in medical research studies, all of the above facts are reasons why men and women must be separated when it comes to medical research.

Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

Clearly, something needs to be done. Women's health needs cannot be ignored any longer. While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Ask the FDA Center for Drug Evaluation and Research to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Sign Here






To the Director of the FDA Center for Drug Evaluation and Research,

I am writing to you today to express my concern after discovering that the FDA does not require medical research and drug trials to separate their findings by the sex of their participants. To get better data on the way women respond to specific drugs and treatment, this must change.

As you are no doubt aware, women and men do not always display the same signs, symptoms, or reactions to treatment. Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

I understand that in 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. I also realize that women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Women need to benefit from medical trials by having researchers separate their data by sex. Please, change your policies to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Thank you,

Petition Signatures


Apr 20, 2018 virginia green
Apr 18, 2018 Laura Scherry
Apr 8, 2018 Ashley Waller
Apr 8, 2018 (Name not displayed)
Apr 6, 2018 Lisa vasta
Apr 6, 2018 (Name not displayed)
Apr 5, 2018 Megan Hockwalt
Apr 3, 2018 KAREN WASSING
Apr 2, 2018 Candace Lewandowski
Apr 2, 2018 Madison Daniels
Apr 2, 2018 Marilena Zlate
Apr 2, 2018 Candice C
Apr 1, 2018 Sandra Bowerman Stop the gender discrimination in medical research.
Apr 1, 2018 JoAnn Loomis
Apr 1, 2018 Bathsheba Rook
Apr 1, 2018 (Name not displayed)
Apr 1, 2018 R Mill
Apr 1, 2018 Lenise Chaffe
Apr 1, 2018 Barbara Tomlinson
Mar 31, 2018 Joyce McCollum
Mar 30, 2018 Denise Griffin
Mar 30, 2018 Elizabeth Wolff
Mar 30, 2018 Loriann Noguchi
Mar 30, 2018 Shawn Cloninger
Mar 29, 2018 Holly Angel
Mar 29, 2018 Penny Dorfman
Mar 29, 2018 james Wrench
Mar 28, 2018 Carolyn Crawford
Mar 28, 2018 (Name not displayed)
Mar 27, 2018 Cindy Page
Mar 27, 2018 Gemma Eggleton
Mar 27, 2018 Gib M
Mar 26, 2018 John Heckler
Mar 26, 2018 Barbara Lintz
Mar 26, 2018 sofia hellgren
Mar 26, 2018 Lori Stevens
Mar 26, 2018 Rebecca Libsack
Mar 26, 2018 (Name not displayed)
Mar 26, 2018 Jen Fitzgerald
Mar 26, 2018 Diane Nelson Roberts
Mar 26, 2018 (Name not displayed)
Mar 26, 2018 (Name not displayed)
Mar 26, 2018 David Meneses B.
Mar 26, 2018 Tatiana Shelenga
Mar 26, 2018 a d
Mar 25, 2018 Heather Kessler
Mar 25, 2018 Mary West
Mar 25, 2018 Kristen Guarino
Mar 24, 2018 Angela Villasenor
Mar 24, 2018 Melanie Burningham

back to top

Offshore Breeze Peekaboo Tunic
Pink Ribbon Woven Walking Shoes
Share this page and help fund mammograms: